Post-approval studies (Phase 4)Study completedNCT01135615
What this trial is testing
Sevelamer, FGF-23 and Endothelial Dysfunction in Chronic Kidney Disease (CKD)
Who this might be right for
We Investigated the Relationship Between Plasma FGF23 Levels and Endothelial Dysfunction in a Sizable Series of Incident Stage 3-4 CKD Patients.
Gulhane School of Medicine 100